pharma · Epilepsy · Allergic Reaction · AQST
Aquestive Therapeutics
Aquestive Therapeutics is a pharma organization headquartered in Vancouver, CA. It trades on NYSE under ticker AQST. Primary therapeutic focus areas include Epilepsy, Allergic Reaction, Nausea and Vomiting, Postoperative
Vancouver, CA HQ
2009 Founded
75 Employees
Public company Type
AQST · NYSE Ticker
Company details
- Status
- Public
- HQ
- Vancouver, CA
- Founded
- 2009
- Employees
- 75
- Programs
- 9
- Drugs
- 9
- Patents
- 17
Ondansetron (ODFS)
Phase 1 · small molecule · Healthy
Ondansetron (ODFS) for Healthy is a Phase 1 program (small_molecule) at Aquestive Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code OND/CR/021/08-09/01906
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Aquestive Therapeutics
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Healthy
- Status
- completed
- Trials
- 1